doi: 10.1136/bmj.1.2978.116.
THE TREATMENT OF AMOEBIC DYSENTERY WITH EMETINE AND BISMUTH IODIDE
- PMID: 20768912
- PMCID: PMC2339908
- DOI: 10.1136/bmj.1.2978.116
Item in Clipboard
THE TREATMENT OF AMOEBIC DYSENTERY WITH EMETINE AND BISMUTH IODIDE
Br Med J.
.
No abstract available
Similar articles
-
THE TREATMENT OF ACUTE AMOEBIC DYSENTERY: TRIALS OF DEHYDROEMETINE, OF DEHYDROEMETINE-BISMUTH-IODIDE, AND OF DEHYDROEMETINE AND DEHYDROEMETINE-BISMUTH-IODIDE IN COMBINATION.Ann Trop Med Parasitol. 1965 Jun;59:205-7. doi: 10.1080/00034983.1965.11720809. Ann Trop Med Parasitol. 1965. PMID: 14345285 No abstract available.
-
A CLINICAL TRIAL OF A NEW COMPOUND (DEHYDROEMETINE BISMUTH IODIDE, RO 4,3076) IN AMOEBIC DYSENTERY.Cent Afr J Med. 1964 Nov;10:412-3. Cent Afr J Med. 1964. PMID: 14238732 No abstract available.
-
DETECTION AND TREATMENT WITH EMETINE BISMUTH IODIDE OF AMOEBIC DYSENTERY CARRIERS AMONG CASES OF IRRITABLE HEART.Br Med J. 1917 Nov 17;2(2968):645-8. doi: 10.1136/bmj.2.2968.645. Br Med J. 1917. PMID: 20768809 Free PMC article. No abstract available.
-
Emetine bismuth iodide in intestinal amoebiasis.Bull Calcutta Sch Trop Med. 1963 Jan;11:33. Bull Calcutta Sch Trop Med. 1963. PMID: 13976073 No abstract available.
-
[Amoebic dysentery].Ryoikibetsu Shokogun Shirizu. 1999;(24 Pt 2):423-6. Ryoikibetsu Shokogun Shirizu. 1999. PMID: 10201245 Review. Japanese. No abstract available.
Cited by
-
Emetine, a small molecule natural product, displays potent anti-gastric cancer activity via regulation of multiple signaling pathways.Cancer Chemother Pharmacol. 2023 Apr;91(4):303-315. doi: 10.1007/s00280-023-04521-y. Epub 2023 Mar 20. Cancer Chemother Pharmacol. 2023. PMID: 36941385 Free PMC article.
-
Emetine exhibits anticancer activity in breast cancer cells as an antagonist of Wnt/β‑catenin signaling.Oncol Rep. 2019 Nov;42(5):1735-1744. doi: 10.3892/or.2019.7290. Epub 2019 Aug 22. Oncol Rep. 2019. PMID: 31436297 Free PMC article.
-
Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axis.Oncotarget. 2016 Nov 8;7(45):73032-73044. doi: 10.18632/oncotarget.12195. Oncotarget. 2016. PMID: 27682876 Free PMC article.
-
Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas.Sci Rep. 2018 Feb 1;8(1):2065. doi: 10.1038/s41598-018-20345-w. Sci Rep. 2018. PMID: 29391537 Free PMC article.
-
Iterative design of emetine-based prodrug targeting fibroblast activation protein (FAP) and dipeptidyl peptidase IV DPPIV using a tandem enzymatic activation strategy.Prostate. 2016 Jun;76(8):703-14. doi: 10.1002/pros.23162. Epub 2016 Feb 2. Prostate. 2016. PMID: 26835873 Free PMC article.
LinkOut - more resources
Full Text Sources